These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29584637)

  • 1. Mutations in the Non-Structural Protein-Coding Sequence of Protoparvovirus H-1PV Enhance the Fitness of the Virus and Show Key Benefits Regarding the Transduction Efficiency of Derived Vectors.
    Hashemi H; Condurat AL; Stroh-Dege A; Weiss N; Geiss C; Pilet J; Cornet Bartolomé C; Rommelaere J; Salomé N; Dinsart C
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29584637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in-frame deletion in the NS protein-coding sequence of parvovirus H-1PV efficiently stimulates export and infectivity of progeny virions.
    Weiss N; Stroh-Dege A; Rommelaere J; Dinsart C; Salomé N
    J Virol; 2012 Jul; 86(14):7554-64. PubMed ID: 22553326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro.
    Geiss C; Kis Z; Leuchs B; Frank-Stöhr M; Schlehofer JR; Rommelaere J; Dinsart C; Lacroix J
    Viruses; 2017 Oct; 9(10):. PubMed ID: 29039746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cytoplasmic sequestration of the nuclear export receptor CRM1 by NS2 mutations developed in the host regulates parvovirus fitness.
    López-Bueno A; Valle N; Gallego JM; Pérez J; Almendral JM
    J Virol; 2004 Oct; 78(19):10674-84. PubMed ID: 15367634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV.
    Dempe S; Stroh-Dege AY; Schwarz E; Rommelaere J; Dinsart C
    Int J Cancer; 2010 Jun; 126(12):2914-27. PubMed ID: 19856310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonstructural protein NS2 of parvovirus H-1 is required for efficient viral protein synthesis and virus production in rat cells in vivo and in vitro.
    Li X; Rhode SL
    Virology; 1991 Sep; 184(1):117-30. PubMed ID: 1831309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The parvovirus H-1 NS2 protein affects viral gene expression through sequences in the 3' untranslated region.
    Li X; Rhode SL
    Virology; 1993 May; 194(1):10-9. PubMed ID: 8480414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells.
    Lacroix J; Leuchs B; Li J; Hristov G; Deubzer HE; Kulozik AE; Rommelaere J; Schlehofer JR; Witt O
    Int J Cancer; 2010 Sep; 127(5):1230-9. PubMed ID: 20087864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The small nonstructural protein (NS2) of the parvovirus minute virus of mice is required for efficient DNA replication and infectious virus production in a cell-type-specific manner.
    Naeger LK; Cater J; Pintel DJ
    J Virol; 1990 Dec; 64(12):6166-75. PubMed ID: 2147041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species.
    Hristov G; Krämer M; Li J; El-Andaloussi N; Mora R; Daeffler L; Zentgraf H; Rommelaere J; Marchini A
    J Virol; 2010 Jun; 84(12):5909-22. PubMed ID: 20375165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid.
    Allaume X; El-Andaloussi N; Leuchs B; Bonifati S; Kulkarni A; Marttila T; Kaufmann JK; Nettelbeck DM; Kleinschmidt J; Rommelaere J; Marchini A
    J Virol; 2012 Apr; 86(7):3452-65. PubMed ID: 22258256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of glioma in rat models by intranasal application of parvovirus h-1.
    Kiprianova I; Thomas N; Ayache A; Fischer M; Leuchs B; Klein M; Rommelaere J; Schlehofer JR
    Clin Cancer Res; 2011 Aug; 17(16):5333-42. PubMed ID: 21715567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages.
    Callaway HM; Feng KH; Lee DW; Allison AB; Pinard M; McKenna R; Agbandje-McKenna M; Hafenstein S; Parrish CR
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvoviral left-end hairpin ears are essential during infection for establishing a functional intranuclear transcription template and for efficient progeny genome encapsidation.
    Li L; Cotmore SF; Tattersall P
    J Virol; 2013 Oct; 87(19):10501-14. PubMed ID: 23903839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.
    Moehler M; Blechacz B; Weiskopf N; Zeidler M; Stremmel W; Rommelaere J; Galle PR; Cornelis JJ
    Cancer Gene Ther; 2001 Mar; 8(3):158-67. PubMed ID: 11332986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete nucleotide sequence and genomic organization of hepatopancreatic parvovirus (HPV) of Penaeus monodon.
    Sukhumsirichart W; Attasart P; Boonsaeng V; Panyim S
    Virology; 2006 Mar; 346(2):266-77. PubMed ID: 16356523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.
    Zhi N; Mills IP; Lu J; Wong S; Filippone C; Brown KE
    J Virol; 2006 Jun; 80(12):5941-50. PubMed ID: 16731932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1.
    Moehler M; Sieben M; Roth S; Springsguth F; Leuchs B; Zeidler M; Dinsart C; Rommelaere J; Galle PR
    BMC Cancer; 2011 Oct; 11():464. PubMed ID: 22029859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.
    Yi M; Ma Y; Yates J; Lemon SM
    J Virol; 2007 Jan; 81(2):629-38. PubMed ID: 17079282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo.
    Lacroix J; Kis Z; Josupeit R; Schlund F; Stroh-Dege A; Frank-Stöhr M; Leuchs B; Schlehofer JR; Rommelaere J; Dinsart C
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29865280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.